Document Classification

Section Type: RESULTS

Text: In the 75 bpm group, ivabradine reduced primary endpoint (HR 0. 76, 95 % CI 0. 68-0. 85, P < 0. 0001), all-cause mortality (HR 0. 83, 95 % CI, 0. 72-0. 96, P = 0. 0109), cardiovascular mortality (HR 0. 83, 95 % CI, (0. 71-0. 97, P = 0. 0166), HF death (HR 0. 61, 95 % CI, 0. 46-0. 81, P < 0. 0006), and HF hospitalization (HR 0. 70, 95 % CI, 0. 61-0. 80, P < 0. 0001).